|
04.05.16
|
|
UBS Neutral
|
Credit Suisse Group
|
|
03.05.16
|
|
Holcim buy
|
Jefferies & Company Inc.
|
|
03.05.16
|
|
UBS Underperform
|
Merrill Lynch & Co., Inc.
|
|
03.05.16
|
|
UBS buy
|
Citigroup Corp.
|
|
03.05.16
|
|
Zurich Insurance Neutral
|
JP Morgan Chase & Co.
|
|
03.05.16
|
|
Swiss Re overweight
|
JP Morgan Chase & Co.
|
|
03.05.16
|
|
ABB (Asea Brown Boveri) Sell
|
Goldman Sachs Group Inc.
|
|
29.04.16
|
|
Swiss Re kaufen
|
DZ-Bank AG
|
|
28.04.16
|
|
Richemont Outperform
|
Robert W. Baird & Co. Incorporated
|
|
28.04.16
|
|
Novartis Neutral
|
UBS AG
|
|
27.04.16
|
|
Nestlé Outperform
|
Robert W. Baird & Co. Incorporated
|
|
27.04.16
|
|
Holcim Neutral
|
JP Morgan Chase & Co.
|
|
27.04.16
|
|
UBS buy
|
Goldman Sachs Group Inc.
|
|
27.04.16
|
|
UBS Neutral
|
Goldman Sachs Group Inc.
|
|
26.04.16
|
|
Novartis Outperform
|
Bernstein Research
|
|
26.04.16
|
|
Roche Outperform
|
Bernstein Research
|
|
26.04.16
|
|
Novartis buy
|
HSBC
|
|
26.04.16
|
|
ABB (Asea Brown Boveri) Sell
|
Goldman Sachs Group Inc.
|
|
26.04.16
|
|
ABB (Asea Brown Boveri) Underperform
|
BNP PARIBAS
|
|
26.04.16
|
|
Novartis Neutral
|
BNP PARIBAS
|
|
25.04.16
|
|
Holcim overweight
|
Morgan Stanley
|
|
25.04.16
|
|
Holcim Neutral
|
Goldman Sachs Group Inc.
|
|
25.04.16
|
|
Novartis overweight
|
JP Morgan Chase & Co.
|
|
22.04.16
|
|
Novartis Underweight
|
Morgan Stanley
|
|
22.04.16
|
|
Richemont buy
|
UBS AG
|
|
22.04.16
|
|
Holcim market-perform
|
Bernstein Research
|
|
22.04.16
|
|
Novartis Equal weight
|
Barclays Capital
|
|
21.04.16
|
|
ABB (Asea Brown Boveri) Sell
|
Citigroup Corp.
|
|
21.04.16
|
|
ABB (Asea Brown Boveri) Equal-Weight
|
Morgan Stanley
|
|
21.04.16
|
|
Holcim Sell
|
Baader Wertpapierhandelsbank
|
|
21.04.16
|
|
ABB (Asea Brown Boveri) Hold
|
Société Générale Group S.A. (SG)
|
|
21.04.16
|
|
Novartis buy
|
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
|
|
21.04.16
|
|
ABB (Asea Brown Boveri) Sell
|
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
|
|
21.04.16
|
|
Holcim Hold
|
Kepler Cheuvreux
|
|
21.04.16
|
|
ABB (Asea Brown Boveri) Neutral
|
JP Morgan Chase & Co.
|
|
21.04.16
|
|
UBS Neutral
|
UBS AG
|
|
20.04.16
|
|
Roche overweight
|
Morgan Stanley
|
|
20.04.16
|
|
ABB (Asea Brown Boveri) Halten
|
Independent Research GmbH
|
|
20.04.16
|
|
Roche overweight
|
JP Morgan Chase & Co.
|
|
20.04.16
|
|
Novartis overweight
|
JP Morgan Chase & Co.
|